Nutrien
Nutrien Ltd. produces and markets crop nutrients worldwide. The last earnings update was 12 days ago. More info.
Add to Portfolio Compare Print
NTR Share Price and Events
7 Day Returns
1 Year Returns
NTR Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| Nutrien (NTR) | 2.1% | 3.9% | 4.6% | 26.7% | - | - |
| CA Chemicals | 3.2% | 7.8% | 0.4% | 22.5% | 61% | -5.6% |
| CA Market | -0.4% | 3.7% | 2.3% | -1.1% | 20.3% | 4.2% |
1 Year Return vs Industry and Market
- NTR outperformed the Chemicals industry which returned 22.5% over the past year.
- NTR outperformed the Market in Canada which returned -1.1% over the past year.
NTR Value
Is Nutrien undervalued based on future cash flows and its price relative to the stock market?
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current
share
price of
Nutrien
to its discounted cash flow analysis.value.The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Below are the data sources, inputs and calculation used to determine the intrinsic value for Nutrien.
| Data Point | Source | Value |
|---|---|---|
| Valuation Model | 2 Stage Free Cash Flow to Equity | |
| Levered Free Cash Flow | Average of 20 Analyst Estimates (S&P Global) | See below |
| Discount Rate (Cost of Equity) | See below | 16.5% |
| Perpetual Growth Rate | 10-Year CA Government Bond Rate | 1.9% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
| Data Point | Calculation/ Source | Result |
|---|---|---|
| Risk-Free Rate | 10-Year CA Govt Bond Rate | 1.9% |
| Equity Risk Premium | S&P Global | 8.1% |
| Chemicals Unlevered Beta | Simply Wall St/ S&P Global | 1.49 |
| Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 1.491 (1 + (1- 26.5%) (28.39%)) |
1.802 |
| Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
1.8 |
| Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.95% + (1.802 * 8.05%) |
16.46% |
Discounted Cash Flow Calculation for TSX:NTR using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for Nutrien is arrived at by discounting future cash flows to their present value using the 2 stage method. We use analyst's estimates of cash flows going forward 5 years for the 1st stage, the 2nd stage assumes the company grows at a stable rate into perpetuity.
| 2019 | 2020 | 2021 | 2022 | 2023 | |
| Levered FCF (USD, Millions) | 2,475.33 | 2,563.61 | 2,680.25 | 3,075.50 | 3,567.58 |
| Source | Analyst x9 | Analyst x11 | Analyst x4 | Analyst x2 | Est @ 16%, capped from 16.56% |
|
Present Value Discounted (@ 16.46%) |
2,125.46 | 1,890.12 | 1,696.80 | 1,671.82 | 1,665.20 |
| Present value of next 5 years cash flows | $9,049.41 |
| Calculation | Result | |
|---|---|---|
| Terminal Value |
= FCF2023
× (1 + g) ÷ (Discount Rate – g)
= $3,567.58 × (1 + 1.95%) ÷ (16.46% – 1.95%) |
$25,058.50 |
| Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)5
= $25,058.50 ÷ (1 + 16.46%)5 |
$11,696.31 |
| Calculation | Result | |
|---|---|---|
| Total Equity Value |
= Present value of next 5 years cash flows +
Terminal Value
= $9,049.41 + $11,696.31 |
$20,745.72 |
| Equity Value per Share (USD) |
= Total value / Shares Outstanding
= $20,745.72 / 609.64 |
$34.03 |
| Calculation | Result | |
|---|---|---|
| Exchange Rate | USD/CAD
(Reporting currency to currency of TSX:NTR) |
1.328 |
| Value per Share (CAD) |
= Value per Share in USD x Exchange Rate (USD/CAD)
= $34.03 x 1.328 |
CA$45.18 |
| Value per share (CAD) | From above. | CA$45.18 |
| Current discount | Discount to share price of
CA$70.76
= -1 x (CA$70.76 - CA$45.18) / CA$45.18 |
-56.6% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
- The current share price of Nutrien is above its future cash flow value.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for Nutrien's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
Nutrien's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2018-12-31) in USD | $-0.05 |
| TSX:NTR Share Price ** | TSX (2019-02-15) in CAD | CA$70.76 |
| TSX:NTR Share Price converted to USD reporting currency | Exchange rate (CAD/ USD) 0.753 | $53.29 |
| Canada Chemicals Industry PE Ratio | Median Figure of 6 Publicly-Listed Chemicals Companies | 13.07x |
| Canada Market PE Ratio | Median Figure of 559 Publicly-Listed Companies | 14.87x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of Nutrien.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = TSX:NTR Share Price ÷ EPS (both in USD) = 53.29 ÷ -0.05 |
-1074.3x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Nutrien is loss making, we can't compare its value to the CA Chemicals industry average.
- Nutrien is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does
Nutrien's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | -1074.3x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 20 Analysts |
39.4%per year |
| North America Chemicals Industry PEG Ratio | Median Figure of 50 Publicly-Listed Chemicals Companies | 1.26x |
| Canada Market PEG Ratio | Median Figure of 261 Publicly-Listed Companies | 0.96x |
*Line of best fit is calculated by linear regression .
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Unable to calculate PEG ratio for Nutrien, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on
Nutrien's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2018-12-31) in USD | $40.14 |
| TSX:NTR Share Price * | TSX (2019-02-15) in CAD | CA$70.76 |
| TSX:NTR Share Price converted to USD reporting currency | Exchange rate (CAD/ USD) 0.753 | $53.29 |
| Canada Chemicals Industry PB Ratio | Median Figure of 30 Publicly-Listed Chemicals Companies | 1.39x |
| Canada Market PB Ratio | Median Figure of 2,329 Publicly-Listed Companies | 1.52x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = TSX:NTR Share Price ÷ Book Value per Share (both in USD) = 53.29 ÷ 40.14 |
1.33x |
* Primary Listing of Nutrien.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Nutrien is good value based on assets compared to the CA Chemicals industry average.
Value checks
We assess Nutrien's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Chemicals industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Chemicals industry average (and greater than 0)? (1 check) Nutrien has a total score of 1/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
NTR Future Performance
How is Nutrien expected to perform in the next 1 to 3 years based on estimates from 20 analysts?
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- Nutrien's earnings growth is expected to exceed the low risk savings rate of 1.9%.
Growth vs Market Checks
- Nutrien's earnings growth is expected to exceed the Canada market average.
- Nutrien's revenue growth is positive but not above the Canada market average.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| TSX:NTR Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 20 Analysts | 39.4% |
| TSX:NTR Future Revenue Growth Rate | Line of Best Fit* through Consensus Estimate Revenue of 20 Analysts | 4.3% |
| Canada Chemicals Industry Earnings Growth Rate | Market Cap Weighted Average | 32.8% |
| Canada Chemicals Industry Revenue Growth Rate | Market Cap Weighted Average | 3.3% |
| Canada Market Earnings Growth Rate | Market Cap Weighted Average | 16.9% |
| Canada Market Revenue Growth Rate | Market Cap Weighted Average | 7.1% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (1 month ago) | See Below |
| Future Estimates | Average of up to 20 Analyst Estimates (S&P Global) | See Below |
| Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * | Avg. No. Analysts |
|---|---|---|---|---|
| 2022-12-31 | 21,839 | 4,277 | 2,238 | 1 |
| 2021-12-31 | 21,395 | 3,912 | 2,143 | 6 |
| 2020-12-31 | 20,869 | 3,872 | 2,059 | 16 |
| 2019-12-31 | 20,197 | 3,555 | 1,799 | 17 |
| Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2018-12-31 | 18,772 | 2,052 | -31 |
| 2018-09-30 | 16,164 | 465 | -447 |
| 2018-06-30 | 13,445 | 935 | 636 |
| 2018-03-31 | 6,518 | 662 | 47 |
| 2017-12-31 | 4,010 | 1,225 | 154 |
| 2017-09-30 | 3,973 | 1,197 | 196 |
| 2017-06-30 | 3,893 | 1,199 | 261 |
| 2017-03-31 | 3,824 | 1,295 | 230 |
| 2016-12-31 | 3,921 | 1,260 | 199 |
| 2016-09-30 | 4,239 | 1,530 | 478 |
| 2016-06-30 | 4,658 | 1,593 | 679 |
| 2016-03-31 | 5,330 | 2,005 | 975 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (1 month ago) | See Below |
| Future Estimates | Average of up to 20 Analyst Estimates (S&P Global) | See Below |
All data from Nutrien Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in USD Millions) | EPS * | EPS High Estimate | EPS Low Estimate | Avg. No. Analysts |
|---|---|---|---|---|
| 2022-12-31 | 3.78 | 3.78 | 3.78 | 1.00 |
| 2021-12-31 | 3.62 | 3.79 | 3.43 | 3.00 |
| 2020-12-31 | 3.38 | 3.84 | 3.05 | 7.00 |
| 2019-12-31 | 2.99 | 3.12 | 2.88 | 7.00 |
| Date (Data in USD Millions) | EPS * |
|---|---|
| 2018-12-31 | -0.05 |
| 2018-09-30 | -0.66 |
| 2018-06-30 | 0.86 |
| 2018-03-31 | 0.06 |
| 2017-12-31 | 0.18 |
| 2017-09-30 | 0.23 |
| 2017-06-30 | 0.31 |
| 2017-03-31 | 0.27 |
| 2016-12-31 | 0.24 |
| 2016-09-30 | 0.57 |
| 2016-06-30 | 0.81 |
| 2016-03-31 | 1.17 |
*GAAP earnings excluding extraordinary items.
Future performance checks
We assess Nutrien's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Nutrien has a total score of 3/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
NTR Past Performance
How has Nutrien performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- Nutrien does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
- Unable to compare Nutrien's 1-year earnings growth to the 5-year average as it is not currently profitable.
- Unable to compare Nutrien's 1-year growth to the North America Chemicals industry average as it is not currently profitable.
Earnings and Revenue History
All data from Nutrien Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in USD Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2018-12-31 | 18,772.00 | -31.00 | 2,876.00 | |
| 2018-09-30 | 16,164.00 | -447.00 | 2,298.00 | |
| 2018-06-30 | 13,445.00 | 636.00 | 1,631.00 | |
| 2018-03-31 | 6,518.00 | 47.00 | 834.00 | |
| 2017-12-31 | 4,010.00 | 154.00 | 233.00 | |
| 2017-09-30 | 3,973.00 | 196.00 | 218.00 | |
| 2017-06-30 | 3,893.00 | 261.00 | 221.00 | |
| 2017-03-31 | 3,824.00 | 230.00 | 233.00 | |
| 2016-12-31 | 3,921.00 | 199.00 | 231.00 | |
| 2016-09-30 | 4,239.00 | 478.00 | 253.00 | |
| 2016-06-30 | 4,658.00 | 679.00 | 246.00 | |
| 2016-03-31 | 5,330.00 | 975.00 | 251.00 | |
| 2015-12-31 | 5,791.00 | 1,115.00 | 258.00 | |
| 2015-09-30 | 6,303.00 | 1,476.00 | 258.00 | |
| 2015-06-30 | 6,402.00 | 1,511.00 | 255.00 | |
| 2015-03-31 | 6,529.00 | 1,566.00 | 250.00 | |
| 2014-12-31 | 6,506.00 | 1,536.00 | 258.00 | |
| 2014-09-30 | 6,152.00 | 1,359.00 | 255.00 | |
| 2014-06-30 | 6,033.00 | 1,398.00 | 254.00 | |
| 2014-03-31 | 6,296.00 | 1,569.00 | 250.00 | |
| 2013-12-31 | 6,733.00 | 1,785.00 | 248.00 | |
| 2013-09-30 | 6,858.00 | 1,976.00 | 218.00 | |
| 2013-06-30 | 7,466.00 | 2,265.00 | 223.00 | |
| 2013-03-31 | 7,742.00 | 2,144.00 | 228.00 | |
| 2012-12-31 | 7,433.00 | 2,079.00 | 219.00 | |
| 2012-09-30 | 7,683.00 | 2,341.00 | 207.00 | |
| 2012-06-30 | 7,886.00 | 2,522.00 | 200.00 | |
| 2012-03-31 | 7,806.00 | 2,840.00 | 199.00 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- It is difficult to establish if Nutrien has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
- Nutrien used its assets less efficiently than the CA Chemicals industry average last year based on Return on Assets.
- It is difficult to establish if Nutrien improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
Past performance checks
We assess Nutrien's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Chemicals industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
Nutrien has a total score of 0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
NTR Health
How is Nutrien's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up Nutrien's finances.
The net worth of a company is the difference between its assets and liabilities.
- Nutrien is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Nutrien's long term commitments exceed its cash and other short term assets.
Balance sheet
Assets
Liabilities and shares
- High level of physical assets or inventory.
- Debt is covered by short term assets, assets are 1.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from Nutrien Company Filings, last reported 1 month ago.
| Date (Data in USD Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2018-12-31 | 24,425.00 | 9,223.00 | 2,314.00 |
| 2018-09-30 | 22,035.00 | 13,366.00 | 1,902.00 |
| 2018-06-30 | 23,700.00 | 12,063.00 | 1,956.00 |
| 2018-03-31 | 23,431.00 | 10,706.00 | 460.00 |
| 2017-12-31 | 8,303.00 | 4,441.00 | 116.00 |
| 2017-09-30 | 8,513.00 | 4,494.00 | 97.00 |
| 2017-06-30 | 8,498.00 | 4,532.00 | 97.00 |
| 2017-03-31 | 8,308.00 | 4,612.00 | 62.00 |
| 2016-12-31 | 8,199.00 | 4,591.00 | 32.00 |
| 2016-09-30 | 8,048.00 | 4,750.00 | 153.00 |
| 2016-06-30 | 8,024.00 | 4,634.00 | 143.00 |
| 2016-03-31 | 8,286.00 | 4,564.00 | 74.00 |
| 2015-12-31 | 8,382.00 | 4,227.00 | 91.00 |
| 2015-09-30 | 8,589.00 | 4,123.00 | 73.00 |
| 2015-06-30 | 9,085.00 | 4,205.00 | 449.00 |
| 2015-03-31 | 8,929.00 | 4,204.00 | 217.00 |
| 2014-12-31 | 8,792.00 | 4,245.00 | 215.00 |
| 2014-09-30 | 8,760.00 | 4,192.00 | 152.00 |
| 2014-06-30 | 8,947.00 | 4,141.00 | 107.00 |
| 2014-03-31 | 9,371.00 | 4,205.00 | 533.00 |
| 2013-12-31 | 9,628.00 | 3,937.00 | 628.00 |
| 2013-09-30 | 9,934.00 | 3,578.00 | 555.00 |
| 2013-06-30 | 10,317.00 | 3,463.00 | 630.00 |
| 2013-03-31 | 10,442.00 | 4,048.00 | 585.00 |
| 2012-12-31 | 9,912.00 | 4,081.00 | 562.00 |
| 2012-09-30 | 9,576.00 | 4,038.00 | 461.00 |
| 2012-06-30 | 8,781.00 | 4,154.00 | 491.00 |
| 2012-03-31 | 8,360.00 | 4,707.00 | 417.00 |
- Nutrien's level of debt (37.8%) compared to net worth is satisfactory (less than 40%).
- The level of debt compared to net worth has been reduced over the past 5 years (40.9% vs 37.8% today).
- Debt is well covered by operating cash flow (22.2%, greater than 20% of total debt).
- Nutrien is making a loss, therefore interest payments are not well covered by earnings.
Financial health checks
We assess Nutrien's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) Nutrien has a total score of 4/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
NTR Dividends
What is Nutrien's current dividend yield, its reliability and sustainability?
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
CA$2,000 of
Nutrien
shares you are expected to receive
CA$65
in your first year as a dividend.
Dividend Amount
- Nutrien's pays a higher dividend yield than the bottom 25% of dividend payers in Canada (2.12%).
- Nutrien's dividend is below the markets top 25% of dividend payers in Canada (5.93%).
Upcoming dividend payment
Purchase Nutrien on or before the 'Buy Limit' to receive their next dividend payment.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 20 Analyst Estimates (S&P Global) | See Below |
| North America Chemicals Industry Average Dividend Yield | Market Cap Weighted Average of 55 Stocks | 2.3% |
| Canada Market Average Dividend Yield | Market Cap Weighted Average of 329 Stocks | 3.6% |
| Canada Minimum Threshold Dividend Yield | 10th Percentile | 1.1% |
| Canada Bottom 25% Dividend Yield | 25th Percentile | 2.1% |
| Canada Top 25% Dividend Yield | 75th Percentile | 5.9% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
| Date (Data in $) | Dividend per Share (annual) | Avg. No. Analysts |
|---|---|---|
| 2022-12-31 | 1.72 | 1.00 |
| 2021-12-31 | 2.02 | 9.00 |
| 2020-12-31 | 1.90 | 16.00 |
| 2019-12-31 | 1.71 | 16.00 |
| Date (Data in $) | Dividend per share (annual) | Avg. Yield (%) |
|---|---|---|
| 2018-12-14 | 1.720 | 3.472 |
| 2018-11-07 | 1.720 | 3.334 |
| 2018-11-06 | 1.720 | 3.010 |
| 2018-11-05 | 1.720 | 3.088 |
| 2018-07-19 | 1.600 | 2.890 |
| 2018-05-24 | 1.600 | 3.038 |
| 2018-02-21 | 1.600 | 3.322 |
| 2018-02-05 | 0.000 | 0.000 |
| 2018-01-02 | 0.400 | 0.753 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- It is too early to tell whether Nutrien has stable dividend payments.
- Nutrien only just started paying a dividend, it is too early to tell if payments are increasing.
Income/ dividend checks
We assess Nutrien's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can Nutrien afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) Nutrien has a total score of 2/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
NTR Management
CEO
| COMPENSATION | $9,713,587 |
| AGE | 48 |
| TENURE AS CEO | 1.7 years |
CEO Bio
Mr. Charles Victor Magro, also known as Chuck, B.Sc. (Chem), MBA is President and Chief Executive Officer of Nutrien Ltd. since June 2, 2017. Mr. Magro served as President and Chief Executive Officer of Agrium Inc. since January 1, 2014 until 2017. His Key skills and experience includes: Mergers & Acquisitions, Strategy and Operations. He joined Agrium in November 2009 as Vice President of Manufacturing following a productive career with NOVA Chemicals, a major petrochemical manufacturer, most recently as Vice President of Investor Relations between 2007 and 2009. He was Executive Vice President, Chief Operating Officer, Executive Vice President, Corporate Development, Chief Risk Officer and Vice President at Agrium. He served as Director of Agrium from 2013 to 2018. He serves on the boards of Canpotex Limited, the Business Council of Canada, the International Fertilizer Association and the International Plant Nutrition Institute. He also serves as chair of The Fertilizer Institute and the Nutrients for Life Foundation. He serves as Director of Nutrien Ltd. since 2018. He has been a Director of Potash Corporation of Saskatchewan Inc. since January 1, 2018.
CEO Compensation
- Chuck's compensation has increased whilst company is loss making.
- Chuck's remuneration is higher than average for companies of similar size in Canada.
Management Team
Chuck Magro
President
$10M
48
1.7 yrs
Mike Frank
Executive VP & CEO of Retail
$11M
54
Pedro Farah
EVP & CFO
Brent Poohkay
Executive VP & Chief Information Officer
48
Mike Webb
Executive VP and Chief Human Resources & Administrative Officer
Richard Downey
Vice President of Investor & Corporate Relations
Joseph Podwika
Executive VP & Chief Legal Officer
55
Kevin Graham
Executive VP & President of Sales
40
Leslie O'Donoghue
Executive Vice President of Strategy & Corporate Development
55
Stephen Dowdle
President of PCS Sales
$1M
67
Board of Directors Tenure
Average tenure and age of the Nutrien board of directors in years:
- The average tenure for the Nutrien board of directors is less than 3 years, this suggests a new board.
Board of Directors
Derek Pannell
Non-Executive Chairman
71
0.4 yrs
Chuck Magro
President
$10M
48
1.1 yrs
Maura Clark
Director
59
1.1 yrs
John Estey
Director
67
1.1 yrs
Keith Martell
Director
55
1.1 yrs
Mayo Schmidt
Director
60
1.1 yrs
Dave Everitt
Director
66
1.1 yrs
Russ Girling
Director
55
1.1 yrs
Jerry Grandey
Director
71
1.1 yrs
Miranda Hubbs
Director
52
1.1 yrs
Who owns this company?
Recent Insider Trading
- More shares have been bought than sold by Nutrien insiders in the past 3 months.
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price (CA$) | Value (CA$) | |
|---|---|---|---|---|---|---|---|---|---|---|
| 14. Feb 19 | Sell | Derek Pannell | Individual | 14. Feb 19 | 14. Feb 19 | -6,221 | CA$71.55 | CA$-445,123 | ||
| 10. Jan 19 | Buy | Aaron Regent | Individual | 27. Dec 18 | 27. Dec 18 | 7,900 | CA$63.43 | CA$501,097 | ||
| 14. Dec 18 | Buy | Michael Webb | Individual | 14. Dec 18 | 14. Dec 18 | 1,000 | CA$63.29 | CA$63,293 | ||
| 19. Dec 18 | Sell | Robert Kirkpatrick | Individual | 09. Nov 18 | 09. Nov 18 | -1,500 | CA$75.25 | CA$-112,875 | ||
| 20. Aug 18 | Sell | Keith Martell | Individual | 17. Aug 18 | 17. Aug 18 | -500 | CA$73.26 | CA$-36,631 | ||
| 03. Aug 18 | Sell | Steven Douglas | Individual | 03. Aug 18 | 03. Aug 18 | -25,000 | CA$73.95 | CA$-1,848,747 | ||
| 12. Jun 18 | Sell | Steven Douglas | Individual | 12. Jun 18 | 12. Jun 18 | -15,000 | CA$68.63 | CA$-1,029,486 | ||
| 01. Jun 18 | Buy | Aaron Regent | Individual | 31. May 18 | 31. May 18 | 15,200 | CA$65.77 | CA$999,704 | ||
| 10. May 18 | Sell | Steven Douglas | Individual | 09. May 18 | 09. May 18 | -15,750 | CA$62.93 | CA$-991,147 | ||
| 09. May 18 | Buy | Michael Webb | Individual | 09. May 18 | 09. May 18 | 3,000 | CA$63.43 | CA$190,277 | ||
| 08. May 18 | Buy | Michael Webb | Individual | 07. Feb 18 | 07. Feb 18 | 2,000 | CA$59.02 | CA$118,037 | ||
| 27. Mar 18 | Buy | Henry Deans | Individual | 26. Mar 18 | 26. Mar 18 | 9,870 | CA$60.72 | CA$599,257 | ||
Management checks
We assess Nutrien's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) Nutrien has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
NTR News
Simply Wall St News
Did Nutrien Ltd (TSE:NTR) Create Value For Investors Over The Past Year?
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it is important. … Another way to think of that is that for every CA$1 worth of equity in the company, it was able to earn CA$0.027. … Return on Equity = Net Profit ÷ Shareholders' Equity
Simply Wall St - – Full articleNutrien Ltd (TSE:NTR): What Are Investors Earning On Their Capital?
and want a simplistic look at the return on Nutrien Ltd (TSE:NTR) stock. … Your return is tied to NTR’s ability to do this because the amount earned is used to invest in opportunities to grow the business or payout dividends, which are the two sources of return on investment. … Thus, to understand how your money can grow by investing in Nutrien, you need to look at what the company returns to owners for the use of their capital, which can be done in many ways but today we will use return on capital employed (ROCE)
Simply Wall St - – Full articleIs Nutrien Ltd (TSE:NTR) A Good Dividend Stock?
In the past, Nutrien Ltd (TSE:NTR) has returned an average of 2.00% per year to investors in the form of dividend payouts. … 5 questions I ask before picking a dividend stock … If you are a dividend investor, you should always assess these five key metrics:
Simply Wall St - – Full articleHow Did Nutrien Ltd's (TSE:NTR) 0.20% ROE Fare Against The Industry?
The content of this article will benefit those of you who are starting to educate yourself about investing in the stock market. … and want a simplistic look at the return on Nutrien Ltd (TSE:NTR) stock. … Nutrien Ltd (TSE:NTR) generated a below-average return on equity of 0.20% in the past 12 months, while its industry returned 8.83%.
Simply Wall St - – Full articleWhat Are Analysts Saying About Nutrien Ltd's (TSE:NTR) Profit Margin?
As analysts forecast … Nutrien Ltd (TSE:NTR) to … earnings growth of 33.93% annualised
Simply Wall St - – Full articleShould You Be Concerned With Nutrien Ltd's (TSE:NTR) -79.57% Earnings Drop?
View our latest analysis for Nutrien Was NTR's recent earnings decline indicative of a tough track record? … I use the ‘latest twelve-month’ data, which annualizes the latest 6-month earnings release, or some times, the latest annual report is already the most recent financial data. … Although revenue growth in the past couple of years, has been negative, earnings growth has been deteriorating by even more, suggesting that Nutrien has been growing its expenses.
Simply Wall St - – Full articleWhat Should Investors Know About Nutrien Ltd's (TSE:NTR) Future Margins?
To help investors get a top level understanding, I will try to evaluate Nutrien's margin behaviour so investors can evaluate the revenue and cost drivers behind future earnings projections and understand how they may impact on returns compared to the industry. … Margin Calculation for NTR Profit Margin = Net Income ÷ Revenue ∴ Profit Margin = 47.00 Million ÷ 6.52 Billion = 0.72% There has been a contraction in Nutrien's margin over the past five years, as a result of net income declining at -28.39% on average, which was quicker than the average fall in revenue of -10.05%, meaning that the decrease in revenue has coincided with a smaller portion falling to the bottom line. … Forward looking projections suggest margins will shift towards expansion, with 8.85% in expected annual revenue growth and annual net income growth forecasted at 34.46%.
Simply Wall St - – Full articleNutrien Ltd (TSE:NTR): Will The Growth Last?
Below, I've presented key growth figures on how market analysts predict Nutrien's earnings growth outlook over the next couple of years and whether the future looks brighter. … View our latest analysis for Nutrien Market analysts' prospects for this coming year seems buoyant, with earnings growth more than doubling. … This means that, we can presume Nutrien will grow its earnings by 41.28% every year for the next couple of years.
Simply Wall St - – Full articleIs Nutrien Ltd (TSE:NTR) Undervalued After Accounting For Its Future Growth?
Nutrien is trading at price-to-earnings (PE) ratio of 250.81x, this also tells us the stock is overvalued based on current earnings compared to the chemicals industry average of 17.97x , and overvalued compared to the CA market average ratio of 15.41x. … TSX:NTR PE PEG Gauge Apr 6th 18 We understand NTR seems to be overvalued based on its current earnings, compared to its industry peers. … This tells us that when we include its growth in our analysis Nutrien's stock can be considered overvalued , based on fundamental analysis.
Simply Wall St - – Full articleWhat does Nutrien Ltd's (TSE:NTR) Balance Sheet Tell Us About Its Future?
At this constant level of debt, the current cash and short-term investment levels stands at US$116.00M for investing into the business. … On top of this, NTR has generated cash from operations of US$1.23B over the same time period, resulting in an operating cash to total debt ratio of 27.58%, meaning that NTR’s current level of operating cash is high enough to cover debt. … Next Steps: NTR’s high cash coverage means that, although its debt levels are high, the company is able to utilise its borrowings efficiently in order to generate cash flow.
Simply Wall St - – Full articleNTR Company Info
Map
Description
Nutrien Ltd. produces and markets crop nutrients worldwide. The company offers potash, nitrogen, phosphate, and solid and liquid phosphate fertilizers; and phosphate feed, ammonium sulfate, and industrial acid products. It also retails seeds, crop protection and crop nutrient products, merchandise products, and agronomic services through operating 1,500 retail locations. The company was incorporated in 2017 and is headquartered in Saskatoon, Canada.
Details
| Name: | Nutrien Ltd. |
| NTR | |
| Exchange: | TSX |
| Founded: | 2017 |
| CA$43,138,126,400 | |
| 609,640,000 | |
| Website: | http://www.nutrien.com |
| Address: |
Nutrien Ltd. 122 – 1st Avenue South, Suite 500, Saskatoon, Saskatchewan, S7K 7G3, Canada |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| TSX | NTR | Common Shares | The Toronto Stock Exchange | CA | CAD | 02. Jan 2018 | |
| NYSE | NTR | Common Shares | New York Stock Exchange | US | USD | 02. Jan 2018 | |
| LSE | 0NHS | Common Shares | London Stock Exchange | GB | USD | 02. Jan 2018 | |
| BMV | NTR N | Common Shares | Bolsa Mexicana de Valores | MX | MXN | 02. Jan 2018 |
Number of employees
Current staff
Industry
| Fertilizers and Agricultural Chemicals | |
| Materials |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/02/18 03:47 |
| End of day share price update: | 2019/02/15 00:00 |
| Last estimates confirmation: | 2019/02/15 |
| Last earnings filing: | 2019/02/06 |
| Last earnings reported: | 2018/12/31 |
| Last annual earnings reported: | 2018/12/31 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
